JPIAMR participating in BIOCOM 2019

JPIAMR is participating in the 12th Berlin Conference on Life Sciences “Novel Antimicrobials and AMR Diagnostics 2019”, 14–15 March 2019, Berlin, Germany.

Two JPIAMR funded projectswill be highlighted within Scientific Session 1 on Academic Innovations: Dr Jean-Claude Sirard will present the project ABIMMUNE, and Dr Robin Michelet will present the project Combinatorials. Both projects were funded within the 2nd JPIAMR Joint Call, Antimicrobial Resistance through the JPIAMR (2015).

Also, Jonathan Pearce, JPIAMR Steering Committee member, will chair as a panelist in the Plenary Session on funding innovation in AMR.

The conference aims to serve as a platform for SME’s, startups, big pharma, academia, investors and governmental institutions to share ideas, discuss support and strategies to bring new antimicrobials and diagnostics to the market. The conference programme includes policy sessions, technology tracks and will be complemented by investor/funder partnering and poster presentations.

Visit the BIOCOM 2019 website here.

Denmark has Joined the Call on AMR Diagnostics and Surveillance

We are very happy to share with you that Denmark has joined the JPIAMR joint call on AMR diagnostics and surveillance.

The total budget for the call is now 20.06 M €.

If you have questions regarding the call, please contact the Call Secretariat via e-mail: JPIAMRCall2019@dlr.de

With more than 40 countries included in the call, it now spans from Europe to Canada to the major part of African countries and beyond Asia with China, India and many other Asian countries included. This creates a host of opportunities for collaboration and truly shows the global reach and capacities of JPIAMR. The full list of criteria to apply for the call is found on the call page.

The call closes on February 18, 2019. So, we encourage everyone to keep sharing the links on Twitter, Facebook and LinkedIn about the call, in order to include even more researchers as applicants. Also, we are keen to spread the information in groups on WhatsApp.

Startup Workshop for Funded Networks

A startup workshop will be taking place in the Netherlands on February 19-20 to kickoff activities for all Networks from the two Transnational Network calls launched by JPIAMR in 2018: JPIAMR Network Call on Surveillance and
JPIAMR-VRI Network Call 2018

Workshop Objectives

The workshop aims to explore opportunities for future research collaborations, synergies and partnerships both between applicants and with external partner, between networks within each call, and between calls if appropriate. In addition to this, the workshop aims to create an overview of network activities within the funding period to enhance alignment and coordination, and support communication of network outputs by the JPIAMR.

Eighteen networks (ten in surveillance and eight in JPIAMR-VRI) have been funded with approximately €50,000 to enhance resource alignment and efforts in the field of AMR surveillance and to help build the JPIAMR-VRI. Two of the funded networks in each of the calls received additional funding to coordinate this start-up meeting. A final workshop is also planned for April 2020.

Trailer – Overview of AMR science policy and funding

JPIAMRs Laura Marin presents the article published in the journal Trends in Microbiology on AMR, science policy, innovation, public health and funding. The article summarises the many recent AMR projects (JPIAMR, TATFAR, CARB-X, GARDP, ND4BB , G7/ G20 Health Ministers, and more) and is a good general reference and entry to the AMR community. The article is co-authored by Arjon Van Hengel (Directorate-General for Research & Innovation, European Commission) and Laura Marin (JPIAMR).

 

Nine New JPIAMR SAB members

JPIAMR is pleased to welcome nine new members to the Scientific Advisory Board, SAB. The new members have diverse experience in the field of AMR, adding key knowledge and experiences to the whole SAB. Now fifthteen members strong.

The following SAB members have been appointed by the JPIAMR Management Board for the period 2019-2021:

  • Till Bachmann, UK
  • Rafael Cantón, Spain
  • Ramanan Laxminarayan, USA and India
  • Marc Lemonnier, France
  • Luísa Vieira Peixe, Portugal
  • Anngret Schneider, Germany
  • Constance Schultsz, Netherlands
  • Ed Topp, Canada
  • Jordi Vila, Spain

For individual biographies and further information, please click here.

Kick-off: ECRAID, the European Clinical Research Alliance on Infectious Diseases

JPIAMR will be participating in a high-level meeting in Brussels, on January 17th 2019, on the development of ECRAID, the European Clinical Research Alliance on Infectious Diseases. ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and AMR, antimicrobial resistance. Laura Marin, JPIAMR Head of Secretariat, will participate in panels, etc.

ECRAID’s vision is to create a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases.  The focus is on two major challenges: emerging infectious diseases with epidemic or pandemic potential, caused by new or re-emerging pathogens, and AMR (antimicrobial resistance). ECRAID will be enable clinical research to be faster and easier having rapid access to and knowledge of developed clinical and laboratory sites. Trials will be conducted continuously to expand on knowledge and experience.

The organisations aim is to protect public health by generating evidence in order to improve diagnosis, prevention, and treatment.  The ECRAID mission is to facilitate and develop world class research to protect citizens of Europe against AMR (antimicrobial resistance) and infectious diseases, over the long term. Professor Herman Goossens together with epidemiologist Marc Bonten, is the project coordinators of ECRAID.

There will be panel discussions with clinical research networks, preclinical research networks, pharmaceutical and diagnostic companies,
SMEs, etc. Together with speakers such as EU Commissioner Carlos Moedas, Herman Goossens, Marc Bonten, Magda Chlebus, Executive Director, Science Policy & Regulatory Affairs, EFPIA and Jeremy Farrar, Director of the Wellcome Trust, and others. This is a closed meeting.

One Health in Focus when EU-JAMRAI Interviews JPIAMRs Laura Marin

In the latest newsletter form EU-JAMRAI, Laura Marin, JPIAMRs Head of Secretariat, is interviewed. The topic is international AMR initiatives and the need of a One Health Approach.

This fits well with JPIAMR’s focus. Our Strategic Research and Innovation Agenda is based on a One Health approach, and the initiatives created by JPIAMR is often centered on global collaboration and coordinating public AMR funding.

The interview was made earlier this year at ECCMID in Spain.

Now Open: Call on AMR Diagnostics and Surveillance

The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and middle income countries (LMICs) in Asia and Africa.

AMR has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to issues such as weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR is pleased to launch this joint transnational call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The total call budget is approx. 20 million Euro.

For full information about the call and the application process, please visit the call page.

The two-step application process (pre-proposal, full proposal) will have the following targeted timetable:

November 15 2018Preannouncement: Antibiotic Awareness Day 2018
December 5 2018Publication of the JPIAMR ERA-NET 2019 Call
February 18 2019 (11:00 CET)Submission deadline for pre-proposals
Mid April 2019Full proposal invitations sent to project coordinators
June 17th 2019 (11:00 CET)Submission deadline for full proposals
Last week September 2019Final funding decision taken by the CSC
Mid October 2019Final funding decision announced to applicants
End of 2019/Early 2020Start of funding

JPIAMR is Partnering on the Call to Action 2018 Conference in Ghana

This is the second global conference on AMR that Wellcome Trust is co-hosting, this time together with the governments of Ghana and Thailand and the United Nations Foundation. The conference takes place in Accra on November 19-20. The Call to Action on AMR 2018, is organised in partnership with the Inter-Agency Coordination Group (IACG) on Antimicrobial Resistance, bringing together stakeholders and pioneering projects.

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) is a growing global collaborative platform, with 27 nations working to curb antibiotic resistance (AMR) with a One Health approach. In that spirit, being a partner is a natural fit.

At the conference, JPIAMR is putting focus on the recently pre-announced AMR Call on Diagnostics and Surveillance. Being included, as a partner in the program and via activities within the conference, the call is communicated together with facts about JPIAMR.

Follow the conference via #CalltoAction18 on Twitter.

Pre-announcement: Call on AMR Diagnostics and Surveillance

JPIAMR is pleased to pre-announce a joint transnational research call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The projected call budget is approx. 20 million Euro.

To read more about the call, please click here.